SCHEMBL30702108

SCHEMBL30702108

Nc1ccc2nc(C(F)(F)F)cnc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ EGFR P00533 2/20 0.41
▸ HDAC4 P56524 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ATM Q13315 2/20 0.40
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ F2 P00734 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ DRD1 P21728 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20364204 1.00 TLR9 (0.50) TLR9KDM4EMAPTEGFRHDAC4
Hydrochloric Acid SCHEMBL28217861 0.98 TLR9 (0.49) TLR9KDM4EMAPTEGFRHDAC4
SCHEMBL30702146 0.93 HDAC4 (0.46) TLR9KDM4EMAPTEGFRHDAC4
SCHEMBL20364203 0.93 HDAC4 (0.46) TLR9KDM4EMAPTEGFRHDAC4
Hydrochloric Acid SCHEMBL28218349 0.91 HDAC4 (0.45) TLR9KDM4EMAPTEGFRHDAC4
SCHEMBL14242807 0.79 ESR2 (0.42) KDM4EMAPTHDAC4KMT2AATM
SCHEMBL13347723 0.79 NQO2 (0.46) KDM4EMAPTEGFRHDAC4HTT
SCHEMBL16112819 0.79 NT5E (0.54) KDM4EMAPTHDAC4HTTLMNA
SCHEMBL29397543 0.79 NT5E (0.54) KDM4EMAPTHDAC4HTTLMNA
SCHEMBL30503643 0.76 LMNA (0.54) KDM4EMAPTEGFRKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292539-B Substituted oxopyridine derivatives 拜耳制药股份公司 2023-12-22 — — CN disclosed
Send feedback